International Scholarly Research Notices / 2013 / Article / Fig 2

Research Article

Improvements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy

Figure 2

(a) CD4+/CD38+/DR+, (b) CD8+/CD38+/DR+, percentage of apoptotic T cells, (c) CD4+/CD95+, (d) CD8+/CD95+. Line represents median; rank-sum test; BL: baseline.
358294.fig.002a
(a)
358294.fig.002b
(b)
358294.fig.002c
(c)
358294.fig.002d
(d)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.